Bioxcel therapeutics to present at jefferies global healthcare conference

New haven, conn., may 28, 2024 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that ceo vimal mehta, ph.d., will present at the jefferies global healthcare conference in new york city. the presentation is set for wednesday, june 5 at 3 p.m. et, and will highlight bioxcel therapeutics' late-stage clinical programs with bxcl501 for the acute treatment of agitation associated with alzheimer's dementia, bipolar disorders, and schizophrenia. dr. mehta will be joined by vincent j. o'neill, m.d., executive vice president, chief of product development and medical officer.
BTAI Ratings Summary
BTAI Quant Ranking